FibroBiologics, Inc. Common StockFBLGNASDAQ
Loading
Enterprise value to EBITDA ratio
Latest
-0.43
↑ 100% vs avg
Percentile
P80
Within normal range
Streak
4 yr
Consecutive growthExpanding
Average
-147.02
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -0.43 | +92.7% |
| 2024 | -5.90 | +90.0% |
| 2023 | -59.00 | +72.9% |
| 2022 | -217.32 | +63.7% |
| 2021 | -599.48 | - |
| 2020 | 0.00 | - |